New Report Presents Strategies and Tactics to Boost Omnichannel Marketing Impact
CHAPEL HILL, N.C., Mar. 23, 2021/PRNewswire/ -- Biopharma marketing is never going to be the same after COVID-19.
Digital marketing is no longer an optional component of a go-to-market strategy for biopharma. To stay ahead of the curve, organizations need to rapidly adopt and integrate new tools and practices to educate key customers, improve reach, enhance speed, raise sales force effectiveness, measure and increase customer satisfaction, and offset declining HCP access.
In a new report, "Omnichannel Marketing: Maximize your Digital Marketing Assets", Best Practices, LLC identifies how leading biopharma companies are adopting an integrated omnichannel marketing strategy by maximizing their key digital assets.
The 102-page study establishes industry benchmarks around digital marketing service structure, digital marketing staffing and investment, digital operations, innovative tools, digitizing new product planning and launch, performance measurement, mobile engagement and digital health, and key channels and activities.
Key topics covered in this report include:
- Digital Marketing Service Structure
- Digital Marketing Staffing & Investment
- Digital Operations
- Innovative Tools & Practices
- Digitizing NPP, Launch & High-Growth Products
- Performance Measurement
- Mobile Engagement & Digital Health
Best Practices, LLC engaged 35 executives from 29 leading life sciences companies in this research through a benchmarking survey. Directors and higher management executives represent nearly 80% of the benchmark participants.
To learn more about this report, download a complimentary report excerpt at https://www.best-in-class.com/rw90.htm.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.